Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
27,995,500
-
Total 13F shares
-
12,887,128
-
Share change
-
+130,529
-
Total reported value
-
$205,289,593
-
Price per share
-
$15.93
-
Number of holders
-
42
-
Value change
-
+$2,132,231
-
Number of buys
-
22
-
Number of sells
-
8
Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q1 2017
As of 31 Mar 2017 Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) had 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,887,128 shares of stock of the company.
Largest 10 holders included Flagship Pioneering Inc., FMR LLC, DEERFIELD MANAGEMENT CO, Redmile Group, LLC, Aisling Capital LLC, BAKER BROS. ADVISORS LP, Casdin Capital, LLC, BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, and VANGUARD GROUP INC.
This table shows 42 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.